I was under the impression that they were original investors in the first version of what is now Admedus Immunotherapies. ie not in AHZ but alongside ahz in the original venture capitalist private investment fund for the vaccine/immunotherapy work.
So while AHZ holds a certain percentage of the Admedus Immunotherapies, the Leiberman's may also still hold their parcel also... along with others.
Vax spin-off / partnership, page-20
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |